UK Menopause Market Size & Outlook, 2024-2030
UK menopause market, 2018-2030 (US$M)
Related Markets
UK menopause market highlights
- The UK menopause market generated a revenue of USD 449.1 million in 2022 and is expected to reach USD 648.1 million by 2030.
- The UK market is expected to grow at a CAGR of 4.7% from 2023 to 2030.
- In terms of segment, dietary supplements was the largest revenue generating treatment in 2022.
- OTC pharma products is the most lucrative treatment segment registering the fastest growth during the forecast period.
Menopause market data book summary
| Market revenue in 2022 | USD 449.1 million |
| Market revenue in 2030 | USD 648.1 million |
| Growth rate | 4.7% (CAGR from 2022 to 2030) |
| Largest segment | Dietary supplements |
| Fastest growing segment | OTC pharma products |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | OTC pharma products, Dietary Supplements |
| Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Other key industry trends
- In terms of revenue, UK accounted for 2.8% of the global menopause market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany menopause market is projected to lead the regional market in terms of revenue in 2030.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 452.9 million by 2030.
Dietary supplements was the largest segment with a revenue share of 93.88% in 2024. Horizon Databook has segmented the UK menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
The NHS has identified the average age of menopause in women as 51 years in the UK, with exceptions that enter menopause before 40 years of age or even in their 30s. It estimated around 13 million women, or around one-third of the female population in the UK, being premenopausal or menopausal. Considering the large target population, researchers are innovating products to ease the transition of women through menopause.
Cambridge Diagnostic Imaging (CaDi), a provider of nutraceutical products for health support, announced the launch of Lycovary Daily in December 2020. The product is a food supplement developed by a biotech company, Lycotec, designed for ovarian health. It provides targeted anti-aging oxygenation, supporting women through the fertile phase and menopause transition.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Menopause Market Scope
Menopause Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK menopause market size, by treatment, 2018-2030 (US$M)
UK Menopause Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
